Latest ANAB reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
AnaptysBio logo
AnaptysBio ANAB
$ 26.23 1.86%

AnaptysBio Financial Statements 2011-2024 | ANAB

Annual Financial Statements AnaptysBio

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

629 M 700 M 953 M 587 M 393 M 1.61 B 2.11 B 312 M - - - - -

Shares

26.9 M 28.2 M 27.4 M 27.3 M 27.1 M 24.7 M 19.8 M 18.2 M - - - - -

Historical Prices

23.4 24.9 34.8 21.5 16.2 63.8 101 - - - - - -

Net Income

-164 M -129 M -57.8 M -19.9 M -97.3 M -61.7 M -30.1 M -4.26 M -5.4 M 3.53 M -5.54 M - -

Revenue

17.2 M 10.3 M 63.2 M 75 M 8 M 5 M 10 M 16.7 M 17.6 M 15.8 M 5.48 M - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-164 M -115 M -56.8 M -23.9 M -107 M -66.7 M -28.8 M -3.02 M -3.32 M - - - -

Interest Expense

-2 K 12 K 37 K -11 K 1.04 M 1.65 M 1.78 M 458 K 460 K - - - -

EBITDA

-164 M -114 M -56.2 M -23.3 M -107 M -66.4 M -28.6 M -2.79 M -3.05 M 5.18 M -4.71 M - -

Operating Expenses

182 M 125 M 120 M 98.9 M 115 M 71.7 M 38.8 M 19.7 M 20.9 M 11 M 10.8 M - -

General and Administrative Expenses

41.9 M 36.6 M 21.5 M 18.9 M 16.1 M 15.5 M 9.34 M 4.29 M 3.59 M 2.35 M 1.95 M - -

All numbers in USD currency

Quarterly Income Statement AnaptysBio

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

26.8 M 26.6 M 26.5 M 26.6 M 28 M 28.5 M 28.3 M 28.2 M 27.7 M 27.6 M 27.4 M 27.4 M 27.4 M 27.4 M 27.3 M 27.3 M 27.3 M 27.3 M 27.1 M 27 M 27 M 26.9 M 24.1 M 23.9 M 23.8 M 23.8 M 20.4 M 20.3 M 15.3 M 2.65 M 2.64 M 2.64 M 2.63 M - - - - - - - - - - - - - - - - - - - -

Net Income

-43.9 M - -37.3 M -39.8 M -44.3 M - -33.5 M -32.6 M -36.3 M - -6.67 M -429 K -18.2 M - -23.8 M -21.5 M -8.26 M -20.3 M -31 M -24 M -22.1 M -17 M -16 M -13.6 M -15.1 M -6.86 M -9.09 M -2.68 M -11.4 M -4.58 M -1.12 M 2.32 M -888 K - - - - - - - - - - - - - - - - - - - -

Revenue

7.18 M - 3.32 M 3.46 M 1.37 M - 1.29 M 1.22 M 970 K - 20.9 M 30 M 11.2 M - - - 15 M - - 5 M - - 5 M - - - - 7 M - - 3.21 M 5.85 M 4.87 M - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-42.2 M - -37.7 M -40.1 M -44.4 M - -29.6 M -27.8 M -31.7 M - -6.76 M -533 K -18.4 M - -24.3 M -22.6 M -10.3 M -22.3 M -33.7 M -26.7 M -24.8 M -19.7 M -16.9 M -14.4 M -15.8 M -7.15 M -9.09 M -2.56 M -9.99 M -3.17 M -1.08 M 2.36 M -1.14 M - - - - - - - - - - - - - - - - - - - -

Interest Expense

-2 K - 1 K 3 K -4 K - 4 K 6 K 6 K - 33 K - 3 K - - - - - 240 K 281 K 320 K - 400 K 436 K 451 K - 452 K 439 K 428 K - 116 K 116 K 115 K - - - - - - - - - - - - - - - - - - - -

EBITDA

-42 M - - - -44.2 M - -29.1 M -27.5 M -31.6 M - -6.31 M -248 K -18.2 M - -23.9 M -22.4 M -10.1 M -22.3 M -33.4 M -26.4 M -24.7 M -19.7 M -16.7 M -14.3 M -15.7 M -7.15 M -8.95 M -2.46 M -9.95 M -3.17 M -900 K 2.48 M -1.08 M - - - - - - - - - - - - - - - - - - - -

Operating Expenses

49.4 M - 41 M 43.6 M 45.8 M - 30.9 M 29 M 32.7 M - 27.7 M 30.6 M 29.6 M - 24.3 M 22.6 M 25.3 M - 33.7 M 31.7 M 24.8 M - 21.9 M 14.4 M 15.8 M - 9.09 M 9.56 M 9.99 M - 4.29 M 3.49 M 6 M - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

12.3 M - 10.2 M 10.7 M 10.8 M - 8.86 M 8.17 M 10.2 M - 5.43 M 5.25 M 5.42 M - 4.79 M 4.69 M 4.28 M - 3.81 M 4.31 M 4.14 M - 4 M 3.83 M 3.95 M - 2.39 M 2.35 M 2.05 M - 1.01 M 1.15 M 1.22 M - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency